Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2018. Start Trial.
Date Value
September 30, 2026 -19.08M
June 30, 2026 -20.48M
March 31, 2026 -19.30M
December 31, 2025 -16.34M
September 30, 2025 -18.98M
June 30, 2025 -26.37M
March 31, 2025 -45.38M
December 31, 2024 -70.77M
September 30, 2024 -99.01M
June 30, 2024 -112.07M
March 31, 2024 -126.78M
December 31, 2023 -131.39M
September 30, 2023 -132.43M
June 30, 2023 -135.82M
March 31, 2023 -127.42M
December 31, 2022 -128.12M
Date Value
September 30, 2022 -118.78M
June 30, 2022 -109.26M
March 31, 2022 -92.94M
December 31, 2021 -73.39M
September 30, 2021 -58.75M
June 30, 2021 -49.46M
March 31, 2021 -44.21M
December 31, 2020 -38.31M
September 30, 2020 -35.72M
June 30, 2020 -31.94M
March 31, 2020 -31.07M
December 31, 2019 -29.59M
September 30, 2019 -24.19M
June 30, 2019 -23.23M
March 31, 2019 -20.03M
December 31, 2018 -20.28M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Agilent Technologies, Inc. 1.267B
Bio-Rad Laboratories, Inc. 329.10M
Bruker Corp. 244.70M
Danaher Corp. 5.727B
Harvard Bioscience, Inc. -3.603M